Pharma groups call for changes to FDA’s potency assurance guidance
Regulatory NewsJoanne S. Eglovitch
Advanced therapies/cell and gene therapyBiologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)Quality Assurance and ControlRegulatory Intelligence/PolicyUnited States